Home Amines 449811-30-7
449811-30-7,MFCD17392922
Catalog No.:AA00DJ5S

449811-30-7 | [6-Chloro-4-(methylamino)pyridin-3-yl]methanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>95%
1 week  
$299.00   $209.00
- +
5mg
>95%
1 week  
$319.00   $223.00
- +
10mg
>95%
1 week  
$358.00   $250.00
- +
500mg
>95%
1 week  
$702.00   $492.00
- +
1g
>95%
1 week  
$963.00   $674.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00DJ5S
Chemical Name:
[6-Chloro-4-(methylamino)pyridin-3-yl]methanol
CAS Number:
449811-30-7
Molecular Formula:
C7H9ClN2O
Molecular Weight:
172.6122
MDL Number:
MFCD17392922
SMILES:
CNc1cc(Cl)ncc1CO
Properties
Computed Properties
 
Complexity:
123  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
1.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:THEUNIVERSITYOFHOUSTONSYSTEM;TRUSTEESOFTUFTSCOLLEGE,INC.-WO2018/213219,2018,A1Locationinpatent:Paragraph0265-0266;0021

[2]CurrentPatentAssignee:FOXCHASECANCERCENTER;TRUSTEESOFTUFTSCOLLEGE,INC.;INSTITUTEFORCANCERRESDBATHERESINTITUTEOFFOXCHASECANCERCENTER;THEUNIVERSITYOFHOUSTONSYSTEM-WO2020/232190,2020,A1Locationinpatent:Paragraph0087;0090;0091;0323;0325;0326

[3]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2013/184119,2013,A1Locationinpatent:Paragraph0195

[4]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2008/33999,2008,A2Locationinpatent:Page/Pagecolumn76

[5]CurrentPatentAssignee:ELILILLY&CO-WO2018/111707,2018,A1Locationinpatent:Page/Pagecolumn55

[6]CurrentPatentAssignee:IRMLLC-WO2008/51757,2008,A1Locationinpatent:Page/Pagecolumn31;32

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/97526,2011,A1Locationinpatent:Page/Pagecolumn31

[8]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-US8461179,2013,B1Locationinpatent:Page/Pagecolumn64

[9]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-WO2014/11900,2014,A2Locationinpatent:Page/Pagecolumn53;54

[10]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[11]CurrentPatentAssignee:INCYTECORP-US2014/315902,2014,A1Locationinpatent:Paragraph0265;0266

[12]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US2015/197519,2015,A1Locationinpatent:Paragraph0139;0140

[13]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[14]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US9695165,2017,B2Locationinpatent:Page/Pagecolumn40;41

[15]CurrentPatentAssignee:IRMLLC-WO2009/105712,2009,A1Locationinpatent:Page/Pagecolumn35-36

[16]CurrentPatentAssignee:IRMLLC-WO2005/34869,2005,A2Locationinpatent:Page/Pagecolumn40

[1]CurrentPatentAssignee:THEUNIVERSITYOFHOUSTONSYSTEM;TRUSTEESOFTUFTSCOLLEGE,INC.-WO2018/213219,2018,A1Locationinpatent:Paragraph0267-0268;0021

[2]CurrentPatentAssignee:INSTITUTEFORCANCERRESDBATHERESINTITUTEOFFOXCHASECANCERCENTER;FOXCHASECANCERCENTER;TRUSTEESOFTUFTSCOLLEGE,INC.;THEUNIVERSITYOFHOUSTONSYSTEM-WO2020/232190,2020,A1Locationinpatent:Paragraph0087;0092;0093;0323;0327;0328

[3]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2008/33999,2008,A2Locationinpatent:Page/Pagecolumn76

[4]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2013/184119,2013,A1Locationinpatent:Paragraph0196

[5]CurrentPatentAssignee:IRMLLC-WO2008/51757,2008,A1Locationinpatent:Page/Pagecolumn31;32

[6]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/97526,2011,A1Locationinpatent:Page/Pagecolumn31

[7]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-US8461179,2013,B1Locationinpatent:Page/Pagecolumn64

[8]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-WO2014/11900,2014,A2Locationinpatent:Page/Pagecolumn53;54

[9]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[10]CurrentPatentAssignee:INCYTECORP-US2014/315902,2014,A1Locationinpatent:Paragraph0265;0266

[11]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US2015/197519,2015,A1Locationinpatent:Paragraph0141;0142

[12]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[13]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US9695165,2017,B2Locationinpatent:Page/Pagecolumn41

[14]CurrentPatentAssignee:IRMLLC-WO2009/105712,2009,A1Locationinpatent:Page/Pagecolumn35;37

[15]CurrentPatentAssignee:IRMLLC-WO2005/34869,2005,A2Locationinpatent:Page/Pagecolumn40

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/97526,2011,A1

[2]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-US8461179,2013,B1CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2013/184119,2013,A1

[3]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[4]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[5]CurrentPatentAssignee:IRMLLC-WO2009/105712,2009,A1

[6]CurrentPatentAssignee:IRMLLC-WO2005/34869,2005,A2

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/97526,2011,A1

[2]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-US8461179,2013,B1

[3]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2013/184119,2013,A1

[4]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[5]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[6]CurrentPatentAssignee:IRMLLC-WO2009/105712,2009,A1

[7]CurrentPatentAssignee:IRMLLC-WO2005/34869,2005,A2

[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2011/97526,2011,A1

[2]CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-US8461179,2013,B1CurrentPatentAssignee:DECIPHERAPHARMACEUTICALSLLC-WO2013/184119,2013,A1

[3]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-WO2014/11900,2014,A2

[4]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[5]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US2015/197519,2015,A1

[6]Montoir,David;Tonnerre,Alain;Duflos,Muriel;Bazin,Marc-Antoine[EuropeanJournalofOrganicChemistry,2014,vol.2014,#7,p.1487-1495]

[7]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US9695165,2017,B2

[8]CurrentPatentAssignee:ELILILLY&CO-WO2018/111707,2018,A1

[9]CurrentPatentAssignee:IRMLLC-WO2009/105712,2009,A1

[10]CurrentPatentAssignee:IRMLLC-WO2005/34869,2005,A2

[11]CurrentPatentAssignee:THEUNIVERSITYOFHOUSTONSYSTEM;TRUSTEESOFTUFTSCOLLEGE,INC.-WO2018/213219,2018,A1

[12]CurrentPatentAssignee:INSTITUTEFORCANCERRESDBATHERESINTITUTEOFFOXCHASECANCERCENTER;FOXCHASECANCERCENTER;TRUSTEESOFTUFTSCOLLEGE,INC.;THEUNIVERSITYOFHOUSTONSYSTEM-WO2020/232190,2020,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 449811-30-7
Tags:449811-30-7 Molecular Formula|449811-30-7 MDL|449811-30-7 SMILES|449811-30-7 [6-Chloro-4-(methylamino)pyridin-3-yl]methanol